Collegium Pharmaceutical ... (COLL)
29.69
0.13 (0.44%)
At close: Mar 28, 2025, 3:59 PM
29.54
-0.52%
Pre-market: Mar 31, 2025, 04:00 AM EDT
Collegium Pharmaceutical Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | 69.19M | 48.16M | -25M | 71.52M | 26.75M | -22.72M | -39.13M | -74.86M | -94.18M | -27.25M | -17.92M | -16.2M |
| Depreciation & Amortization | 163.28M | 149.26M | 138.94M | 68.92M | 61.55M | 15.48M | 110.91M | 594K | 655K | 171K | 187K | 169K |
| Stock-Based Compensation | 32.4M | 27.14M | 22.87M | 24.25M | 21.91M | 16.53M | 13.78M | 7.95M | 5.79M | 2.21M | 22K | 62K |
| Other Working Capital | n/a | -1.09M | -38.5M | 44.13M | -10.43M | 20.92M | 126.1M | 9.26M | 10.59M | 2.04M | -1.21M | 188K |
| Other Non-Cash Items | -33.07M | 30.62M | 8.52M | 3.42M | 9.03M | 313K | 19.28M | -34K | -34K | -28K | -20K | -9K |
| Deferred Income Tax | -26.81M | -2.15M | -8.39M | -78.04M | n/a | n/a | n/a | 1.84M | n/a | n/a | n/a | 79K |
| Change in Working Capital | n/a | 21.73M | -12.71M | 13.49M | -25.3M | 18.18M | 64.55M | -2.5M | 12.71M | 3.34M | -219K | -634K |
| Operating Cash Flow | 204.98M | 274.75M | 124.23M | 103.56M | 93.94M | 27.78M | 169.39M | -67.02M | -75.05M | -21.57M | -17.95M | -16.53M |
| Capital Expenditures | -1.65M | -461K | -1.62M | -1.94M | -373.77M | -6.44M | -24.35M | -990K | -2.98M | -362K | -8K | -206K |
| Acquisitions | -267.54M | n/a | -572.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -111.17M | -92.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 92.6M | 22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | -368.23M | n/a | -18.88M | n/a | -2.5M | n/a | n/a | n/a |
| Investing Cash Flow | -287.76M | -70.81M | -573.69M | -1.94M | -373.77M | -6.44M | -24.35M | -990K | -2.98M | -362K | -8K | -206K |
| Debt Repayment | 7.52M | -65.92M | 442.68M | -50M | 281.39M | n/a | 10.02M | -2.67M | -2.67M | -1.34M | 11.97M | 395K |
| Common Stock Repurchased | -60.02M | -75M | -14.06M | -47.86M | -2.25M | -822K | -560K | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24.57M | -24.57M | n/a | n/a |
| Other Financial Acitivies | -8.1M | 740K | 8.1M | 8.56M | 5.08M | 2.04M | -127.19M | 1.81M | 885K | 69.88M | 72K | 11.96M |
| Financial Cash Flow | -60.6M | -140.18M | 436.72M | -89.3M | 286.47M | 2.04M | -117.2M | 33.48M | 135.56M | 115.99M | 12.04M | 12.35M |
| Net Cash Flow | -143.38M | 63.76M | -12.74M | 12.31M | 6.64M | 23.39M | 27.84M | -34.53M | 57.53M | 94.06M | -5.92M | -4.38M |
| Free Cash Flow | 203.33M | 274.29M | 122.61M | 101.61M | -279.83M | 21.34M | 145.04M | -68.01M | -78.03M | -21.93M | -17.95M | -16.74M |